Pages that link to "Q37091154"
Jump to navigation
Jump to search
The following pages link to Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells (Q37091154):
Displaying 50 items.
- Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors (Q21245468) (← links)
- Nanoparticles for brain drug delivery (Q21285117) (← links)
- Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer (Q26828849) (← links)
- Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide (Q27010580) (← links)
- Cancer nanotechnology: emerging role of gold nanoconjugates (Q27021820) (← links)
- Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. (Q27316967) (← links)
- A review of nanoparticle functionality and toxicity on the central nervous system (Q28383491) (← links)
- Nanoparticles for imaging and treating brain cancer (Q28394053) (← links)
- Current approaches to enhance CNS delivery of drugs across the brain barriers (Q30437835) (← links)
- Pharmacodynamic analysis of magnetic resonance imaging-monitored focused ultrasound-induced blood-brain barrier opening for drug delivery to brain tumors (Q30455361) (← links)
- Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model (Q30528069) (← links)
- Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier (Q30672749) (← links)
- Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer (Q30997567) (← links)
- Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside (Q31065446) (← links)
- Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis (Q33622573) (← links)
- Tissue concentration of systemically administered antineoplastic agents in human brain tumors (Q33844823) (← links)
- Multimodality imaging probes: design and challenges (Q33884695) (← links)
- Review of Neurosurgical Fluorescence Imaging Methodologies (Q34023717) (← links)
- Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability (Q34083937) (← links)
- A nanoparticle size series for in vivo fluorescence imaging (Q34557863) (← links)
- Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging (Q34714550) (← links)
- Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors (Q35602796) (← links)
- Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer. (Q35624110) (← links)
- Cellular imaging of endosome entrapped small gold nanoparticles (Q35685020) (← links)
- Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers. (Q36454892) (← links)
- A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma (Q36478915) (← links)
- Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury (Q36520379) (← links)
- Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles (Q36625112) (← links)
- A choline derivate-modified nanoprobe for glioma diagnosis using MRI. (Q36747329) (← links)
- Recent advances in RNA interference therapeutics for CNS diseases (Q36983193) (← links)
- Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life (Q37209324) (← links)
- Targeting Glioma with a Dual Mode Optical and Paramagnetic Nanoprobe across the Blood-brain Tumor Barrier (Q37296161) (← links)
- Determining molecular mass distributions and compositions of functionalized dendrimer nanoparticles. (Q37340127) (← links)
- Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors (Q37346039) (← links)
- New strategies to deliver anticancer drugs to brain tumors (Q37364700) (← links)
- Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma (Q37668050) (← links)
- Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas (Q37689021) (← links)
- Drug or vaccine?: selecting the appropriate treatment for malignant glioma patients (Q37778052) (← links)
- Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations (Q37823446) (← links)
- Health impact and safety of engineered nanomaterials (Q37863477) (← links)
- Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications (Q37919627) (← links)
- Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs (Q37959770) (← links)
- Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery (Q37995554) (← links)
- Recent advances in brain tumor-targeted nano-drug delivery systems (Q38011262) (← links)
- Which drug or drug delivery system can change clinical practice for brain tumor therapy? (Q38090394) (← links)
- PAMAM dendrimer roles in gene delivery methods and stem cell research (Q38090586) (← links)
- Targeted delivery of nano-therapeutics for major disorders of the central nervous system. (Q38116765) (← links)
- Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies. (Q38121378) (← links)
- Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches (Q38136249) (← links)
- Patented nanomedicines for the treatment of brain tumors (Q38163012) (← links)